625 related articles for article (PubMed ID: 19451510)
21. Subcutaneous dermatofibrosarcoma protuberans in skin of the breast: may mimic a primary breast lesion.
Bulliard C; Murali R; Chang LY; Brennan ME; French J
Pathology; 2007 Aug; 39(4):446-8. PubMed ID: 17676490
[No Abstract] [Full Text] [Related]
22. Dermatofibrosarcoma protuberans: 35 patients treated with Mohs micrographic surgery using paraffin sections.
Tan WP; Barlow RJ; Robson A; Kurwa HA; McKenna J; Mallipeddi R
Br J Dermatol; 2011 Feb; 164(2):363-6. PubMed ID: 20973768
[TBL] [Abstract][Full Text] [Related]
23. CD34-positive myxoid dermatofibrohistiocytoma of the skin: an indolent post-traumatic tumor that can be mistaken for dermatofibrosarcoma protuberans.
Al-Quran SZ; Russo JJ; Bandarchi-Chamkhaleh B; Hassanein AM
J Cutan Pathol; 2009 Jan; 36(1):84-6. PubMed ID: 19125740
[No Abstract] [Full Text] [Related]
24. Transformation of recurrent dermatofibrosarcoma protuberans to its pigmented variant (Bednar tumour).
Rytina ER; Ball RY
Histopathology; 1998 Apr; 32(4):384-5. PubMed ID: 9602345
[No Abstract] [Full Text] [Related]
25. Clinical and pathological changes in a long-term follow-up case of dermatofibrosarcoma protuberans.
Yamamoto Y; Toyozawa S; Uede K; Oda Y; Nakamura Y; Furukawa F
J Dermatol; 2011 Feb; 38(2):203-5. PubMed ID: 21269323
[No Abstract] [Full Text] [Related]
26. Immunohistochemical characterization of dermatofibrosarcoma protuberans with practical applications for diagnosis and treatment.
Haycox CL; Odland PB; Olbricht SM; Piepkorn M
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):438-44. PubMed ID: 9308560
[TBL] [Abstract][Full Text] [Related]
27. Neurofibromatous changes in dermatofibrosarcoma protuberans: a potential pitfall in the diagnosis of a serious cutaneous soft tissue neoplasm.
Kovarik CL; Hsu MY; Cockerell CJ
J Cutan Pathol; 2004 Aug; 31(7):492-6. PubMed ID: 15239679
[TBL] [Abstract][Full Text] [Related]
28. [Pigmented fibrosarcomatous dermatofibrosarcoma protuberans (Bednar tumor). 3 case reports, analogy with the "conventional" type and review of the literature].
Bisceglia M; Vairo M; Calonje E; Fletcher CD
Pathologica; 1997 Jun; 89(3):264-73. PubMed ID: 9380420
[TBL] [Abstract][Full Text] [Related]
29. Pigmented dermatofibrosarcoma protuberans (Bednár tumor) occurring in a Japanese infant.
Kaburagi Y; Hatta N; Kawara S; Takehara K
Dermatology; 1998; 197(1):48-51. PubMed ID: 9693186
[TBL] [Abstract][Full Text] [Related]
30. Pigmented dermatofibrosarcoma protuberans. Report of two cases as a variant of dermatofibrosarcoma protuberans with partial neural differentiation.
Nakamura T; Ogata H; Katsuyama T
Am J Dermatopathol; 1987 Feb; 9(1):18-25. PubMed ID: 3551654
[TBL] [Abstract][Full Text] [Related]
31. An unusual pigmented skin tumour. Bednar Tumour, dorsum of left foot (pigmented dermatofibrosarcoma protuberans).
Zardawi IM; Kattampallil J; Rode J
Pathology; 2004 Aug; 36(4):358-61. PubMed ID: 15370137
[No Abstract] [Full Text] [Related]
32. Dermatofibrosarcoma protuberans treated with Mohs surgery. A case with CD34 immunostaining variability.
Garcia C; Viehman G; Hitchcock M; Clark RE
Dermatol Surg; 1996 Feb; 22(2):177-9. PubMed ID: 8608381
[TBL] [Abstract][Full Text] [Related]
33. Dermatofibrosarcoma protuberans: is mohs surgery truly superior? And the success of tyrosine kinase inhibitors.
Kallini JR; Khachemoune A
J Drugs Dermatol; 2014 Dec; 13(12):1474-7. PubMed ID: 25607791
[TBL] [Abstract][Full Text] [Related]
34. Tenascin differentiates dermatofibroma from dermatofibrosarcoma protuberans: comparison with CD34 and factor XIIIa.
Kahn HJ; Fekete E; From L
Hum Pathol; 2001 Jan; 32(1):50-6. PubMed ID: 11172295
[TBL] [Abstract][Full Text] [Related]
35. Dermatofibrosarcoma: a rare form of soft tissue. Management and review of the literature.
Kontzoglou K; Stamatakos M; Polyzou E; Levidou G; Iannescu R; Safioleas M
Chirurgia (Bucur); 2011; 106(5):653-6. PubMed ID: 22165066
[TBL] [Abstract][Full Text] [Related]
36. Expression of embryonic stem cell markers SOX2 and nestin in dermatofibrosarcoma protuberans and dermatofibroma.
Sellheyer K; Nelson P; Patel RM
J Cutan Pathol; 2011 May; 38(5):415-9. PubMed ID: 21251041
[TBL] [Abstract][Full Text] [Related]
37. A study of CD117 expression in dermatofibrosarcoma protuberans and cellular dermatofibroma.
Labonte S; Hanna W; Bandarchi-Chamkhaleh B
J Cutan Pathol; 2007 Nov; 34(11):857-60. PubMed ID: 17944726
[TBL] [Abstract][Full Text] [Related]
38. Primary dermatofibrosarcoma protuberans of orbit--a rare entity.
Rahman T; Bhattacharjee K; Sarma JD; Dey D; Kuri G
Orbit; 2013 Apr; 32(2):127-9. PubMed ID: 23448305
[TBL] [Abstract][Full Text] [Related]
39. Dermatofibrosarcoma protuberans with unusual sarcomatous transformation: a series of 4 cases with molecular confirmation.
Swaby MG; Evans HL; Fletcher CD; Prieto VG; Patel KU; Lev DC; Lòpez-Terrada D; Lazar AJ; Wang WL
Am J Dermatopathol; 2011 Jun; 33(4):354-60. PubMed ID: 21478726
[TBL] [Abstract][Full Text] [Related]
40. Bednar tumor.
Kuruvila S; Ramadan FA
Saudi Med J; 2004 Dec; 25(12):2016-7. PubMed ID: 15711690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
